Placental growth factor for pre‐eclampsia screening before 11 weeks' gestation

Documenti analoghi

• Screening for pre‐eclampsia with competing‐risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestation
  di: I. Riishede, et al.
  Pubblicazione: (2024)
• Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
  di: N. Sokratous, et al.
  Pubblicazione: (2024)
• Role of routine uterine artery Doppler at 18–22 and 24–28 weeks' gestation following routine first‐trimester screening for pre‐eclampsia
  di: E. Bonacina, et al.
  Pubblicazione: (2024)
• Angiogenic factor levels across severity stages of fetal smallness with or without associated pre‐eclampsia
  di: L. Youssef, et al.
  Pubblicazione: (2026)
• Comparison of different methods of first‐trimester screening for preterm pre‐eclampsia: cohort study
  di: D. Cuenca‐Gómez, et al.
  Pubblicazione: (2024)